conv.

All stories
HealthRunning 1m

QuantHealth raises $45M Series B for AI clinical trial simulation

Tel Aviv-based startup QuantHealth secures funding led by Qumra Capital to expand AI-driven drug development simulations.

8 items0 engagement0 comments Techmeme

Conversation activity · last 24 hours peak 8/hr

Peak 8 items in one hour at Aug 9, 9 PM; 8 items over 24 hours Aug 9, 10 AM — no itemsAug 9, 11 AM — no itemsAug 9, 12 PM — no itemsAug 9, 1 PM — no itemsAug 9, 2 PM — no itemsAug 9, 3 PM — no itemsAug 9, 4 PM — no itemsAug 9, 5 PM — no itemsAug 9, 6 PM — no itemsAug 9, 7 PM — no itemsAug 9, 8 PM — no itemsAug 9, 9 PM — 8 itemsAug 9, 10 PM — no itemsAug 9, 11 PM — no itemsAug 10, 12 AM — no itemsAug 10, 1 AM — no itemsAug 10, 2 AM — no itemsAug 10, 3 AM — no itemsAug 10, 4 AM — no itemsAug 10, 5 AM — no itemsAug 10, 6 AM — no itemsAug 10, 7 AM — no itemsAug 10, 8 AM — no itemsAug 10, 9 AM — no items 8 items · 9 PM
Aug 10

Summary, timeline and people extracted by Claude from 8 items across 1 source · 1h ago. Quotes are verbatim.

QuantHealth, a Tel Aviv-based provider of AI clinical trial simulation software, raised $45 million in Series B funding led by Qumra Capital, bringing total funding to approximately $70 million. The funding will accelerate the company's simulation-first approach to clinical trial development, allowing pharmaceutical companies to test trial designs and reduce development risk before enrolling patients or spending billions on trials.

  • QuantHealth raised $45M Series B led by Qumra Capital, bringing total funding to ~$70M.
  • The Tel Aviv-based company provides AI clinical trial simulation software to help pharma test designs before patient enrollment.
  • Funding aims to accelerate simulation-first clinical trial development and reduce drug development risk and costs.

How it unfolded

  1. Report Funding announced across media

    News of QuantHealth's Series B round was published across major health tech and business publications including Fierce Healthcare, Business Wire, Axios, and Digital Health News on the same date, indicating a coordinated announcement.

  2. Event QuantHealth Series B funding closed

    QuantHealth completed a $45 million Series B funding round led by Qumra Capital. The round brings the company's total funding to approximately $70 million.

What people are saying verbatim

“QuantHealth Raises $45 Million Series B, led by Qumra Capital, to Accelerate Simulation-First Clinical Trial Development”

Business Wire · Business Wire ↗ · Aug 9

“QuantHealth Secures $45 Mn to Expand AI Clinical Trial Simulations & Help Pharma Reduce Drug Development Risk”

Digital Health News · Digital Health News ↗ · Aug 9

“QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll”

MedCity News · MedCity News ↗ · Aug 9